微信内可能无法直接打开本站。请点右上角 ··· → 在浏览器打开，或复制链接。
STAT+: Eli Lilly targets booming black market for retatrutide
RSS 官方收录 · 可信分层展示
关键摘要
Want to stay on top of the science and politics driving biotech today?Sign up to get our biotech newsletter in your inbox.…
- There’s limited access to California’s cheap insulin, Eli Lilly’s crac…
- Some rather buff fellows at my gym were comparing abdomens today, ravi…
- ” I imagine they won’t be too pleased about the Lilly news.
摘要引擎：抽取
正文提要
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
There’s limited access to California’s cheap insulin, Eli Lilly’s cracking down on black market retatrutide, and new biotech Khartis Therapeutics emerges with $95 million.
Some rather buff fellows at my gym were comparing abdomens today, raving about the bodysculpting wonders of all that illicit “reta.” I imagine they won’t be too pleased about the Lilly news.